project id: TCGA-UCEC; case submitter id: TCGA-B5-A11X; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 66; days to birth: -24217; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1944; age at diagnosis: 24217; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 596.0; figo stage: Stage IIIC2; icd 10 code: C54.1; last known disease status: not reported; morphology: 8020/3; primary diagnosis: Carcinoma, undifferentiated, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 246; days to sample procurement: 0; initial weight: 530.0; portion submitter id: TCGA-B5-A11X-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 10.0; percent normal cells: 20.0; percent stromal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0;